insulin sensitivity: nootropics and compounds | sci-wiki

Amlexanox

Amlexanox is a small-molecule anti-inflammatory long approved as a topical paste for aphthous ulcers, now repurposed in research as a selective inhibitor of the noncanonical inflammatory kinases IKKe and TBK1. By blocking these kinases it raises energy expenditure and has produced weight loss, improved insulin sensitivity, and reduced fatty liver in obese mice, with a human trial showing improved glucose control in a responsive subgroup [1][2]. This dual identity, an established ulcer drug with an emerging metabolic mechanism, makes it one of the more intriguing drug-repurposing candidates in metabolic research.

1 outlet

Supplement

Dihydroberberine

Dihydroberberine (DHB) is a reduced, or hydrogenated, form of berberine; basically the same molecule with two extra hydrogen atoms tacked on. Once it hits the gut it gets converted right back to berberine, so you end up with all the familiar berberine effects (blood sugar control, better lipids, AMPK activation) but from a much smaller dose. The whole reason DHB exists is absorption. Plain berberine is notoriously hard to get into the bloodstream, so DHB is the clever workaround. Think of it as the same engine with a better fuel line; nothing new downstream, just far more of it actually reaching your cells. People reach for it for the same goals as berberine: steadier blood sugar, improved insulin sensitivity, healthier cholesterol and triglycerides, and that "exercise in a pill" AMPK effect on the cell's energy machinery.

1 outlet

Mineral

Magnesium Chloride

Magnesium chloride is a highly soluble inorganic salt of the essential mineral magnesium, made of one magnesium ion and two chloride ions (MgCl2). It is used as a dietary supplement to raise or maintain magnesium status, and it is also the magnesium form behind topical "magnesium oil," a concentrated MgCl2 solution applied to the skin [1][5]. Because it dissolves and ionizes fully, the chloride form is absorbed on par with other soluble magnesium salts and better than magnesium oxide, though the fraction taken up is still modest like every magnesium supplement [1].

1 outlet

Antidiabetic

Dapagliflozin

Dapagliflozin is a prescription medication of the SGLT2 inhibitor, or gliflozin, class, sold under brand names such as Farxiga and Forxiga. One of the first drugs in its class, it is used to treat type 2 diabetes, chronic heart failure, and chronic kidney disease. It works in the kidney by blocking a transporter that reabsorbs glucose, so that more sugar is passed out in the urine, and it also produces benefits for the heart and kidneys that reach beyond blood sugar control. It is taken once daily by mouth.

1 outlet

Antidiabetic

Pioglitazone

Pioglitazone is an oral antidiabetic medicine of the thiazolidinedione class, used to improve blood sugar control in type 2 diabetes. Marketed as Actos, it works as an insulin sensitizer, activating a nuclear receptor called PPAR-gamma to make the body's tissues respond better to insulin. Effective at lowering blood glucose and with additional effects on fat and the liver, it is nonetheless used carefully because of side effects that include fluid retention, weight gain, and a debated association with bladder cancer.

1 outlet

Blend

Pioglitazone + Metformin

Pioglitazone plus metformin is a fixed-dose combination tablet that unites two oral diabetes medicines with complementary actions: pioglitazone, a thiazolidinedione that makes tissues more sensitive to insulin, and metformin, a biguanide that mainly reduces the amount of glucose released by the liver. It is used to improve blood sugar control in adults with type 2 diabetes whose condition is not adequately managed on metformin alone. Combining the two drugs in a single pill is intended to lower blood sugar more fully while simplifying treatment, and it is marketed under names such as ACTOplus Met and Competact.

1 outlet

Cardiovascular

Saroglitazar

Saroglitazar is an oral dual PPAR-alpha and PPAR-gamma agonist of the glitazar class, developed in India for metabolic disorders. It is used mainly to treat diabetic dyslipidemia and hypertriglyceridemia, and it has been studied for non-alcoholic fatty liver disease and related conditions. By activating two nuclear receptor subtypes it lowers blood triglycerides while also improving insulin resistance and blood sugar.

1 outlet

Cardiovascular

Acipimox

Acipimox is a synthetic derivative of nicotinic acid (niacin) used as a lipid-lowering medication. It is prescribed mainly to lower elevated triglycerides and, to a lesser degree, to raise HDL cholesterol in people with certain forms of hyperlipidemia. Marketed in parts of Europe under the trade name Olbetam, it is generally regarded as having a milder side-effect profile than niacin itself.

reference

PPAR Modulator

Aleglitazar

Aleglitazar is a dual peroxisome proliferator-activated receptor (PPAR) alpha/gamma agonist that was developed by Hoffmann-La Roche as an oral treatment for type 2 diabetes. Its large Phase III cardiovascular outcomes trial (AleCardio) was halted early for safety signals and lack of efficacy, and all development was discontinued in 2013.

reference

Supplement

JBSNF-000088

JBSNF-000088 is a small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT), a cytosolic enzyme that methylates nicotinamide using S-adenosylmethionine [1]. Originally reported as a nicotinamide analogue that reduces 1-methylnicotinamide levels and improves insulin sensitivity and body weight in obese and diabetic mice, it has since become a widely used NNMT-inhibitor tool compound in cancer and metabolic research [1]. Notably, it is not a TAAR1 agonist or monoamine modulator; its target is NNMT.

reference